Malnutrition in systemic sclerosis

Rheumatology (United Kingdom)

Volumn 51, Issue 10, 2012, Pages 1747-1756

  Harrison, Elizabeth ^a   Herrick, Ariane L ^b   Mclaughlin, John T ^a   Lal, Simon ^c  

^a Academic Health Sciences Centre   (United Kingdom)

^b NONE   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Enteral nutrition; Gastrointestinal; Malnutrition; Parenteral nutrition; Scleroderma; SSc

Indexed keywords

ANOREXIA; ANXIETY DISORDER; ARTICLE; BACTERIAL OVERGROWTH; BARRETT ESOPHAGUS; BODY MASS; CARDIOVASCULAR DISEASE; CONSTIPATION; DECREASED APPETITE; DENTAL CARIES; DEPRESSION; DYSPHAGIA; ENTERIC FEEDING; ESOPHAGITIS; FUNCTIONAL STATUS; GASTRIC DYSMOTILITY; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRANSIT; HEALTH; HUMAN; INCREASED APPETITE; INFLAMMATION; INTESTINAL DYSMOTILITY; LOWER ESOPHAGUS SPHINCTER; LUNG DISEASE; MALABSORPTION; MALNUTRITION; NUTRITIONAL COUNSELING; NUTRITIONAL SUPPORT; PERISTALSIS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SCREENING; STOMACH PARESIS; SYSTEMIC SCLEROSIS; UNITED KINGDOM; XEROSTOMIA;

DISEASE PROGRESSION; HUMANS; MALNUTRITION; NUTRITION ASSESSMENT; NUTRITIONAL STATUS; SCLERODERMA, SYSTEMIC;

EID: 84867114249     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes160     Document Type: Article

References (99)

1. Allcock RJ, Forrest I, Corris A, Crook PR, Griffiths ID. A study of the prevalence of systemic sclerosis in northeast England. Rheumatology 2004;43:596-602.
2. Chizzolini C, Brembilla NC, Montanari E, Truchetet ME. Fibrosis and immune dysregulation in systemic sclerosis. Autoimmun Rev 2011;10:276-81.
3. Russell ML, Friensen D, Hendersen RD, Hanna WM. Ultrastructure of the oesophagus in scleroderma. Arthrtis Rheum 1982;25:1117-23.
4. Cerinic MM, Generini S, Pignone A, Casale R. The nervous system in systemic sclerosis (scleroderma). Scleroderma 1996;22:879-92.
5. Thoua NM, Bunce C, Brough G et al. Assessment of gastrointestinal symptoms in patients with systemic sclerosis in a UK tertiary referral centre. Rheumatology 2010;49:1770-75.
6. Baron M, Hudson M, Steele R., Canadian Scleroderma Group. Malnutrition is common in systemic sclerosis: results from the Canadian scleroderma research group database. J Rheumatol 2009;36:2737-43.
7. Krause L, Becker MO, Brueckner CS et al. Nutritional status as marker for disease activity and severity predicting mortality in patients with systemic sclerosis. Ann Rheum Dis 2010;69:1951-57.
8. Brown M, Teubner A, Shaffer J, Herrick AL. Home parenteral nutrition-an effective and safe long-term therapy for systemic sclerosis-related intestinal failure. Rheumatology 2008;47:176-9.
9. Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007;66: 940-4.
10. Baubet T, Ranque B, Taieb O et al. Mood and anxiety disorders in systemic sclerosis patients. Presse Med 2011;40:e111-9.
11. Ostojic P, Zivojinovic S, Reza T, Damjanov N. Symptoms of depression and anxiety in Serbian patients with systemic sclerosis: impact of disease severity and socioeconomic factors. Mod Rheumatol 2010; 20:353-7.
12. Singleton N, Bumpstead R, O'Brien M, Lee A, Meltzer H. Psychiatric morbidity among adults living in private households, 2000. Int Rev Psychiatry 2003;15:65-73.
13. Moussavi S, Chatterji S, Verdes E et al. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007;370: 851-8.
14. Bland P. Improving recognition of generalised anxiety disorder. Practitioner 2011;255:25-8.
15. Thombs BD, Fuss S, Hudson M et al. High rates of depressive symptoms among patients with systemic sclerosis are not explained by differential reporting of somatic symptoms. Arthritis Rheum 2008;59: 431-7.
16. Ingraham KM, Steen VD. Morbidity of digital tip ulcerations in scleroderma [abstract]. Arthritis Rheum 2006;54: P578.
17. Berezne A, Seror R, Morell-Dubois S et al. Impact of systemic sclerosis on occupational and professional activity with attention to patients with digital ulcers. Arthritis Care Res (Hoboken) 2011;63:277-85.
18. Nguyen C, Poiraudeau S, Mestre-Stanislas C et al. Employment status and socio-economic burden in systemic sclerosis: a cross-sectional survey. Rheumatology 2010;49:982-9.
19. Sharif R, Mayes MD, Nocassio PM et al. Determinants of work disability in patients with systemic sclerosis: a longitudinal study of the GENISOS cohort. Semin Arthritis Rheum 2011;41:38-47.
20. Medsger TA Jr, Silman AJ, Steen VD et al. A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 1999;26:2159-67.
21. Vincent C, Agard C, Barbarot S et al. Orofacial manifestations of systemic sclerosis: a study of 30 consecutive patients. Rev Med Interne 2009;30:5-11.
22. Mouthon L, Rannou F, Berezne A et al. Development and validation of a scale for mouth handicap in systemic sclerosis: the Mouth Handicap in Systemic Sclerosis scale. Ann Rheum Dis 2007;66:1651-55.
23. Khovidhunkit SO, Suwantunula T, Thaweboon S et al. Xerostomia, hyposalivation and oral microbiota in type 2 diabetic patients: a preliminary study. J Med Assoc Thai 2009;92:1220-8.
24. Poole JL, Brewer C, Rossie K et al. Factors related to oral hygiene in persons with scleroderma. Int J Dent Hyg 2005; 3:13-17.
25. Wood RE, Lee P. Analysis of the oral manifestations of systemic sclerosis (scleroderma). Oral Surg Oral Med Oral Pathol 1988;65:172-8.
26. Hung HC, Willett W, Ascherio A et al. Tooth loss and dietary intake. J Am Dent Assoc 2003;134:1185-92.
27. Roberts CG, Hummers LK, Ravich WJ, Wigley FM, Hutchins GM. A case-control study of the pathology of oesophageal disease in systemic sclerosis (scleroderma). Gut 2006;55:1697-703.
28. Santos-Navarro RR, Méndez-del-Monte R, del Real-Calzada C, Vera-Lastra OL. Clinical, endoscopic and manometric findings in the gastroesophageal tract of patients with systemic sclerosis. Rev Med Inst Mex Seguro Soc 2008;46:503-10.
29. Bhalla M, Silver RM, Shepard JA, McLoud TC. Chest CT in patients with scleroderma: prevalence of asymptomatic esophageal dilatation and mediastinal lymphadenopathy. AJR Am J Roentgenol 1993;161:269-72.
30. Pitrez EH, Bredemeier M, Xavier RM et al. Oesophageal dysmotility in systemic sclerosis: comparison of HRCT and scintigraphy. Br J Radiol 2006;79:719-24.
31. Zamost BJ, Hirschberg J, Ippoliti AF et al. Esophagitis in scleroderma. Prevalence and risk factors. Gastroenterology 1987;92:421-8.
32. Marie I, Ducrotte P, Denis P, Hellot MF, Levesque H. Oesophageal mucosal involvement in patients with systemic sclerosis receiving proton pump inhibitor therapy. Aliment Pharmacol Ther 2006;24:1593-601.
33. Lahcene M, Oumnia N, Matougui N et al. Esophageal involvement in scleroderma: clinical, endoscopic and manometric features. ISRN Rheumatol 2011;2011:325826.
34. Lunderg AC, Akesson A, Akesson B. Dietary intake and nutritional status in patients with systemic sclerosis. Ann Rheum Dis 1992;51:1143-8.
35. British Association for Parenteral and Enteral Nutrition. Malnutrition Universal Screening Tool. www.bapen.org.uk/ pdfs/must/must-full.pdf (24 May 2012, date last accessed).
36. Sridhar KR, Lange RC, Magyar L, Soykan I, McCallum RW. Prevalence of impaired gastric emptying of solids in systemic sclerosis: diagnostic and therapeutic implications. J Lab Clin Med 1998;132:541-6.
37. Marie I, Levesque H, Ducrotte P et al. Gastric involvement in systemic sclerosis: a prospective study. Am J Gastroenterol 2001;96:77-83.
38. Manetti M, Milia AF, Benelli G et al. The gastric wall in systemic sclerosis patients: a morphological study. Ital J Anat Embryol 2010;115:115-21.
39. McNearney TA, Sallam HS, Hunnicutt SE et al. Gastric slow waves, gastrointestinal symptoms and peptides in systemic sclerosis patients. Neurogastroenterol Motil 2009;21:1269-e120.
40. Parkman HP, Yates K, Hasler WL et al. Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity. Gastroenterology 2011;140: 101-15.
41. Horowitz M, Maddern GJ, Maddox A et al. Effects of cisapride on gastric and esophageal emptying in progressive systemic sclerosis. Gastroenterology 1987;93: 311-5.
42. Marie I, Levesque H, Ducrotte P et al. Manometry of the upper intestinal tract in patients with systemic sclerosis. A prospective study. Arthritis Rheum 1998;41: 1874-83.
43. Weston S, Thumshirn M, Wiste J, Camilleri M. Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders. Am J Gastroenterol 1998;93: 1085-9.
44. Marie I, Ducrotte P, Denis P, Menard JM, Levesque H. Small intestinal bacterial overgrowth in systemic sclerosis. Rheumatology 2009;48:1314-9.
45. Parodi A, Sessarego M, Greco A et al. Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication. Am J Gastroenterol 2008;103:1257-62.
46. Kaye SA, Lim SG, Taylor M et al. Small bowel bacterial overgrowth in systemic sclerosis: detection using direct and indirect methods and treatment outcome. Br J Rheumatol 1995;34:265-9.
47. Verne GN, Eaker EY, Hardy E, Sninsky CA. Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudo-obstruction. Dig Dis Sci 1995;40:1892-901.
48. Nikou GC, Toumpanakis C, Katsiari C, Charalambopoulos D, Sfikakis PP. Treatment of small intestinal disease in systemic sclerosis with octreotide: a prospective study in seven patients. J Clin Rheumatol 2007;13:119-23.
49. Malcolm A, Ellard K. Intestinal perforation associated with octreotide therapy in scleroderma. Am J Gastroenterol 2001;96:3206-8.
50. Wang SJ, Lan JL, Chen DY et al. Colonic transit in systemic sclerosis. Clin Rheumatol 2001;20:251-4.
51. Ishikawa M, Okada J, Kondo H. Five cases of systemic sclerosis with associated with intestinal pseudo-obstruction. Ryumachi 1999;39:768-73.
52. Norman GL, Bialek A, Encabo S et al. Is prevalence of PBC underestimated in patients with systemic sclerosis? Dig Liv Dis 2009;41:762-4.
53. Assassi S, Fritzler MJ, Arnett FC et al. Primary biliary cirrhosis (PBC), PBC autoantibodies and hepatic parameter abnormalities in a large population of systemic sclerosis patients. J Rheumatol 2009;36: 2250-56.
54. Myers RP, Shaheen AA, Fong A et al. Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: a population-based study. Hepatology 2009;50:1884-92.
55. Phillips JR, Angulo P, Petterson T, Lindor KD. Fat-soluble vitamin levels in patients with primary biliary cirrhosis. Am J Gastroenterol 2001;96:2745-50.
56. Hendel L, Worning H. Exocrine pancreatic function in patients with progressive systemic sclerosis. Scand J Gastroenterol 1989;24:461-6.
57. Abraham AA, Joos A. Pancreatic necrosis in progressive systemic sclerosis. Ann Rheum Dis 1980;39:396-8.
58. Karaahmet T, Tigen K, Gurel E et al. Impact of systemic sclerosis on electromechanical characteristics of the heart. Heart Vessels 2010;25:223-8.
59. Tyndall AJ, Bannert B, Vonk M et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 2010;69:1809-15.
60. Vachiery JL, Coghlan G. Screening for pulmonary artery hypertension in systemic sclerosis. Eur Respir Rev 2009; 18:162-9.
61. Vonk MC, Broers B, Heijdra YF et al. Systemic sclerosis and its pulmonary complications in the Netherlands: an epidemiological study. Ann Rheum Dis 2009;68:961-5.
62. Hughes CM, Woodside JV, McGartland C et al. Nutritional intake and oxidative stress in chronic heart failure. Nutr Metab Cardiovasc Dis 2012;22:376-82.
63. Araujo JP, Lourenco P, Rocha-Goncalves F, Ferreria A, Bettencourt P. Nutritional markers and prognosis in cardiac cachexia. Int J Cardiol 2011;146:359-69.
64. Calanas-Continente AJ, Cervero Pluvins C, Munoz Gomariz E et al. Prevalence of malnutrition among candidates for lung transplantation. Nutr Hosp 2002;17: 197-203.
65. Kuhlmann MK, Levin NW. Potential interplay between nutrition and inflammation in dialysis patients. Contrib Nephrol 2008;161:76-82.
66. Kalantar-Zadeh K, Anker SD, Horwich TB, Fonarow GC. Nutritional and anti-inflammatory interventions in chronic heart failure. Am J Cardiol 2008;101:89E-103E.
67. McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 2009;12:223-6.
68. Targońska-Stepniak B, Majdan M. Associations between parameters of nutritional status and disease activity in patients with rheumatoid arthritis. Pol Arch Med Wewn 2011;121:122-8.
69. Lal S, Kirkup AJ, Brunsden AM, Thompson DG, Grundy D. Vagal afferent responses to fatty acids of different chain length in the rat. Am J Physiol Gastrointest Liver Physiol 2001;281:G907-15.
70. Lal S, McLaughlin J, Barlow J et al. Cholecystokinin pathways modulate sensations induced by gastric distension in humans. Am J Physiol Gastrointest Liver Physiol 2004;287:G72-9.
71. Lock G, Straub RH, Zeuner M et al. Association of autonomic nervous dysfunction and esophageal dysmotility in systemic sclerosis. J Rheumatol 1998;25:1330-5.
72. Ferri C, Emdin M, Giuggioli D et al. Autonomic dysfunction in systemic sclerosis: time and frequency domain 24 hour heart rate variability analysis. Br J Rheumatol 1997;36: 669-76.
73. McDermott JR, Leslie FC, D'Amato M et al. Immune control of food intake: enteroendocrine cells are regulated by CD4+ T lymphocytes during small intestinal inflammation. Gut 2006;55:492-7.
74. Danese C, Caiola S, Lucia P et al. Relationship among VIP plasma levels, esophageal dysfunction, and microcirculation in systemic sclerosis. Minerva Med 2000;91:185-9.
75. Baron M, Bernier P, Cote LF et al. Screening and therapy for malnutrition and related gastro-intestinal disorders in systemic sclerosis: recommendations of a North American expert panel. Clin Exp Rheumatol 2010;28:S42-46.
76. National Institute of Clinical Excellence. GC32 Nutrition Support in Adults. February 2006.
77. Mueller C, Compher C, Ellen DM. A.S.P.E.N. clinical guidelines: nutrition screening, assessment, and intervention in adults. JPEN J Parenter Enteral Nutr 2011;35: 16-24.
78. Kondrup J, Allison SP, Elia M, Vellas B, Plauth M. ESPEN guidelines for nutrition screening 2002. Clin Nutr 2003;22: 415-21.
79. Stratton RJ, Hackston A, Longmore D et al. Malnutrition in hospital outpatients and inpatients: prevalence, concurrent validity and ease of use of the 'malnutrition universal screening tool' ('MUST') for adults. Br J Nutr 2004;92: 799-808.
80. Baron M, Hudson M, Steele R., Canadian Scleroderma Research Group. Is serum albumin a marker of malnutrition in chronic disease? The scleroderma paradigm. J Am Coll Nutr 2010;29:144-51.
81. Stratton RJ, Hackson A, Longmore D et al. Malnutrition in hospital outpatients and inpatients: prevalence, concurrent validity and easy use of the 'malnutrition universal screening tool' ('MUST') for adults. Br J Nutr 2004;92: 799-808.
82. Velasco C, Garcia E, Rodriguez V et al. Comparison of four nutritional screening tools to detect nutritional risk in hospitalized patients: a multicentre study. Eur J Clin Nutr 2011;65:269-74.
83. Assassi S, del Junco D, Sutter K et al. Clinical and genetic factors predictive of mortality in early systemic sclerosis. Arthritis Rheum 2009;61:1403-11.
84. Herrick AL, Worthington H, Rieley F et al. Dietary intake of micronutrient antioxidants in relation to blood levels in patients with systemic sclerosis. J Rheumatol 1996;23: 650-3.
85. Brueckner CS, Becker MO, Kroencke T et al. Effect of sidenafil on digital ulcers in systemic sclerosis: analysis form a single centre pilot study. Ann Rheum Dis 2010;69: 1475-8.
86. Boeckxataens GE, Bartelsman WM, Lauwers L, Tygat GNJ. Treatment of GI dysmotility in scleroderma with the new enteric agent prucalopride. Am J Gastroenterol 2002;97:194-7.
87. Johnson SR, Carette S, Dunne JV. Scleroderma: health service utilization from patient's perspective. J Rheumatol 2006;33:1123-7.
88. Lemoignan J, Chasen M, Bhargava R. A retrospective study of the role of the occupational therapist in the cancer nutrition rehabilitation program. Support Care Cancer 18:1589-96.
89. Poole JR, Conte C, Brewer C et al. Oral hygiene in scleroderma: the effectiveness of a multi-disciplinary intervention program. Disabil Rehabil 2010;32: 379-84.
90. Laforest S, Goldin B, Nour K, Roy MA, Payette H. Nutritional risk in home-bound older adults: using dietician-trained and supervised nutritional volunteers for screening and intervention. Can J Aging 2007;26: 305-15.
91. Persson M, Hytter-Landahl A, Brismar K, Cederholm T. Nutritional supplementation and dietary advice in geriatric patients at risk of malnutrition. Clin Nutr 2007;26: 216-24.
92. Keld R, Kinsey L, Athwal V, Lal S. Pathogenesis, investigation and dietary and medical management of gastroparesis. J Hum Nutr Diet 2011;24:421-30.
93. Fynne L, Kruse A, Borre M, Sondergaard K, Krogh K. Percutaneous endoscopic gastrostomy in patients with systemic sclerosis. Scand J Rheumatol 2010;39: 266-8.
94. Johnson DA, Drane WE, Curran J et al. Pulmonary disease in progressive systemic sclerosis. A complication of gastroesophageal reflux and occult aspiration? Arch Intern Med 1989;149:589-93.
95. Lyons JM, Falkenbach L, Cerra FB. Home parenteral nutrition with full-time home care nurses. J Parenter Enter Nutr 1981;5:528-30.
96. Ng SC, Clements PJ, Berquist WE, Furst DE, Paulus HE. Home central venous hyperalimentation in fifteen patients with severe scleroderma bowel disease. Arthritis Rheum 1989;32:212-6.
97. Jawa H, Fernandes G, Saqui O, Allard JP. Home parenteral nutrition in patients with systemic sclerosis: a retrospective review of 12 cases. J Rheumatol 2012;39: 1004-7.
98. Winkler MF, Ross VM, Piamjariyakul U, Gajewski B, Smith CE. Technology dependence in home care: impact on patients and their family caregivers. Nutr Clin Pract 2006;21:544-56.
99. Bonifacio R, Alfonsi L, Santarpia L et al. Clinical outcome of long-term home parenteral nutrition in non-oncological patients: a report from two specialised centres. Intern Emerg Med 2007;2:188-95.